Effects of combined dietary supplementation on oxidative and inflammatory status in dyslipidemic subjects

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 16, Issue 2, 2006, Pages 121-127

  Accinni, R ^a   Rosina, M ^b   Bamonti, F ^b   Della Noce, C ^a   Tonini, A ^a   Bernacchi, F ^c   Campolo, J ^a   Caruso, R ^a   Novembrino, C ^b   Ghersi, L ^d   Lonati, S ^b   Grossi, S ^d   Ippolito, S ^b   Lorenzano, E ^b   Ciani, A ^b   Gorini, M ^d  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Riservice Srl Unipro   (Italy)

^d AFaR SC Center of Jesus FBF SColombano al Lambro   (Italy)

Author keywords

Dietary supplementation; Dyslipidemia; Inflammatory cytokines; Oxidative stress

Indexed keywords

EID: 33644899375     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.05.006     Document Type: Article

References (36)

1. Hajjar DP, Haberland ME. Lipoprotein trafficking in vascular cells: molecular Trojan horses and cellular saboteurs. J Biol Chem 1997;272:22975-8.
2. Diaz MN, Frei B, Vita JA, Keaneym Jr JF. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.
3. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European Guidelines for Cardiovascular Disease Prevention in Clinical Practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10.
4. Calder PC. N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 2003;38(4):343-52.
5. Christon RA. Mechanism of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis. Nutr Rev 2003;61(8):272-9.
6. Alvarez W, Mobarhan S. Finding a place for immunonutrition. Nutr Rev 2003;61(6):214-8.
7. Mills DE, Murthy M, Galey WR. Dietary fatty acids, membrane transport, and oxidative sensitivity in human erythrocytes. Lipids 1995;30:657-66.
8. Ricciarelli R, Zingg JM, Azzi A. Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 2000;102:82-7.
9. Miller M. Niacin as a component of combination therapy for dyslipidemia. Mayo Clin Proc 2003;78:735-42.
10. Xu Z, Hua N, Godber JS. Antioxidant activity of tocopherols, tocotrienols, and gamma-oryzanol components from rice bran against cholesterol oxidation accelerated by 2, 2′-azobis(2-methylpropionamidine) dihydroclorid. J Agricultural Food Chem 2001;49:2077-81.
11. Rosenson RS. Antiatherothrombotic effects of nicotinic acid. Atherosclerosis 2003;171:87-96.
12. Ogata S, Tacheuchi M, Teradaira S, et al. Radical scavenging activities of niacin-related compounds. Biosci Biotechnol Biochem 2002;66:641-5.
13. Ungerstedt JS, Blomback M, Soderstrom T. Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 2003;131(1):48-52.
14. Birjmohun RS, Hutten BA, Kastelein JJP, Stroes ESG. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds. J Am Coll Cardiol 2005;45:185-97.
15. Capuzzi DM, Morgan JM, Brusco Jr OA, Intenzo CM. Niacin dosing: relationship to benefits and adverse effects. Curr Atheroscler Rep 2000;2:64-71.
16. Rong N, Ausman LM, Nicolosi R. Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipids 1997;32(3):303-9.
17. Cicero AFG, Gaddi A. Rice bran oil and γ-oryzanol in the treatment of hyperlipoproteinaemias and other conditions. Phytother Res 2001;15:277-89.
18. Carratelli R, Barbieri M, Miceli G, Bosone D, Rondanelli P, Bo P. Oxidative stress and thromboembophilic conditions in alcoholics without severe liver disease. Haematologica 2001;86:85-91.
19. Alberti A, Bolognini L, Macciantelli D, Carratelli M. The radical cation of N, N-diethyl-para-phenylendiamine: a possibile indicator of oxidative stress in biological samples. Res Chem Intermed 2000;26(3):253-67.
20. Teissier E, Walters-Laport E, Duhem C, Luc G, Fruchert JC, Duriez P. Rapid quantification of α-tocopherol in plasma and low-and high-density lipoproteins. Clin Chem 1996;42(3):430-5.
21. Maxey KM, Maddipati KR, Birkimeier J. Interference in enzyme immunoassays. J Clin Immunoassay 1992;15:116-20.
22. Pradelles P, Grassi J, Maclouf J. Enzyme-immunoassays of eicosanoids using acetylcholinesterase as label: an alternative to radioimmunoassays. Anal Chem 1985;57:1170-3.
23. Nordoy A, Marchioli R, Arnesen H, Videbaek J. N-3 polyunsaturated fatty acids and cardiovascular diseases. Lipids 2001;36(Suppl.):S127-9.
24. Phillipson BE, Rothrock WD, Connor WE, Harris W, Illingwort R. Reduction of plasma lipids, lipoproteins and apoproteins by dietary fish oils in patients with hypertriglyceridemia. N Engl J Med 1985;312:1210-6.
25. Mayer K, Gokorsch S, Fegbeutel C, et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003;167:1321-8.
26. McKenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med 2004;164:697-705.
27. Pischonl T, Hankinson SE, Hotamisligil GS, Rifai N, Willett WC, Rimm EB. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003;108:155-60.
28. Calder PC. Dietary modification of inflammation with lipids. Proc Nutr Soc 2002;61:345-58.
29. Obata T, Nagakura T, Masaki T, Maekawa K, Yamashita K. Eicosapentaeinoic acid inhibits prostaglandin D2 generation by inhibiting cyclo-oxigenase-2 in cultured human mast cells. Clin Exp Allergy 1999;29:1129-35.
30. Curtis CL, Hughes CE, Flannery CR, Little CB, Harwood JL, Caterson B. N-3 fatty acids specifically modulate catabolic factors Involved in articular cartilage degradation. J Biol Chem 2000;275:721-74.
31. De Caterina R, Cybulsky MI, Clinton SK, Gimbrone Jr MA, Libby P. The omega-3 fatty acids docosahexanoate reduces citokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. Arterioscler Thromb 1994;14(11):1829-36.
32. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr 2000;71(1):213-23.
33. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. The effect on human tumor necrosis factor alpha and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116-22.
34. Caughey GE, Pouliot M, Cleland LG, James MJ. Regulation of tumor necrosis factor alpha and interleukin-1 beta synthesis by thromboxane A2 in non-adherent human monocytes. J Immunol 1997;158:351-8.
35. Grimminger F, Wahn H, Mayer K, Kiss L, Walmrath D, Seeger W. Impact of arachidonic versus eicosapentaenoic acid on exotonin-induced lung vascular leakage: relation to 4-series versus 5-series leukotriene generation. Am J Respir Crit Care Med 1997;155:513-9.
36. Goldberg AC. A meta-analysis of randomized controlled studies on the effects of extended-release niacin in women. Am J Cardiol 2004;94:121-4.